The clinical relevance of autoantibodies in scleroderma
Open Access
- 1 January 2003
- journal article
- review article
- Published by Springer Science and Business Media LLC in Arthritis Research & Therapy
- Vol. 5 (2), 80-93
- https://doi.org/10.1186/ar628
Abstract
No abstract availableKeywords
This publication has 118 references indexed in Scilit:
- Identity of the RNase MRP– and RNase P–associated Th/To autoantigenArthritis & Rheumatism, 2002
- Diversity and plasticity of the anti-DNA topoisomerase I autoantibody response in sclerodermaArthritis & Rheumatism, 2000
- Longitudinal analysis of autoantibody response to topoisomerase I in systemic sclerosisArthritis & Rheumatism, 2000
- Longitudinal Study of Anticentromere and Antitopoisomerase-I IsotypesClinical Immunology and Immunopathology, 1995
- Clinical manifestations in anticardiolipin antibody-positive patients with progressive systemic sclerosisJournal of the American Academy of Dermatology, 1990
- Marker antibodies in scleroderma and polymyositis: Clinical associationsClinical Rheumatology, 1989
- Clinical associations of anticentromere antibodies and antibodies to topoisomerase i. a study of 355 patientsArthritis & Rheumatism, 1988
- Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosisArthritis & Rheumatism, 1988
- Autoantibody to RNA polymerase I in scleroderma sera.JCI Insight, 1987
- Human anticentriole autoantibody in patients with scleroderma and Raynaud's phenomenonClinical Immunology and Immunopathology, 1983